BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 15583526)

  • 1. Treatment of menopausal vasomotor symptoms.
    Med Lett Drugs Ther; 2004 Dec 6-20; 47(1197-1198):98-9. PubMed ID: 15583526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of menopause-associated vasomotor symptoms: position statement of The North American Menopause Society.
    North American Menopause Society
    Menopause; 2004; 11(1):11-33. PubMed ID: 14716179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of black cohosh-containing preparations on menopausal symptoms: a meta-analysis.
    Shams T; Setia MS; Hemmings R; McCusker J; Sewitch M; Ciampi A
    Altern Ther Health Med; 2010; 16(1):36-44. PubMed ID: 20085176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaginal, endometrial, and reproductive hormone findings: randomized, placebo-controlled trial of black cohosh, multibotanical herbs, and dietary soy for vasomotor symptoms: the Herbal Alternatives for Menopause (HALT) Study.
    Reed SD; Newton KM; LaCroix AZ; Grothaus LC; Grieco VS; Ehrlich K
    Menopause; 2008; 15(1):51-8. PubMed ID: 18257142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lessons learned from the Women's Health Initiative trials of menopausal hormone therapy.
    Rossouw JE; Manson JE; Kaunitz AM; Anderson GL
    Obstet Gynecol; 2013 Jan; 121(1):172-6. PubMed ID: 23262943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review of alternative therapies for treatment of menopausal symptoms.
    Amato P; Marcus DM
    Climacteric; 2003 Dec; 6(4):278-84. PubMed ID: 15006249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose estrogen therapy for menopausal women: a review of efficacy and safety.
    Crandall C
    J Womens Health (Larchmt); 2003 Oct; 12(8):723-47. PubMed ID: 14588124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating the evidence for over-the-counter alternatives for relief of hot flashes in menopausal women.
    Kelley KW; Carroll DG
    J Am Pharm Assoc (2003); 2010; 50(5):e106-15. PubMed ID: 20833608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Menopause: evidence-based practice.
    Blake J
    Best Pract Res Clin Obstet Gynaecol; 2006 Dec; 20(6):799-839. PubMed ID: 17084674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficacy and safety of Black cohosh (Actaea/Cimicifuga racemosa) in the treatment of vasomotor symptoms--review of clinical trials].
    Kanadys WM; LeszczyƄska-Gorzelak B; Oleszczuk J
    Ginekol Pol; 2008 Apr; 79(4):287-96. PubMed ID: 18592868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of menopausal vasomotor symptoms.
    Obstet Gynecol; 2005 May; 105(5 Pt 1):1137-9. PubMed ID: 15863558
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of low-dose hormone therapy on menopausal symptoms, bone mineral density, endometrium, and the cardiovascular system: a review of randomized clinical trials.
    Peeyananjarassri K; Baber R
    Climacteric; 2005 Mar; 8(1):13-23. PubMed ID: 15804728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MF-101, an estrogen receptor beta agonist for the treatment of vasomotor symptoms in peri- and postmenopausal women.
    Stovall DW; Pinkerton JV
    Curr Opin Investig Drugs; 2009 Apr; 10(4):365-71. PubMed ID: 19337958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of menopausal hormones in the United States, 1992 through June, 2003.
    Wysowski DK; Governale LA
    Pharmacoepidemiol Drug Saf; 2005 Mar; 14(3):171-6. PubMed ID: 15386701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Approach to the patient with menopausal symptoms.
    Martin KA; Manson JE
    J Clin Endocrinol Metab; 2008 Dec; 93(12):4567-75. PubMed ID: 19056840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogens and progestins: background and history, trends in use, and guidelines and regimens approved by the US Food and Drug Administration.
    Stefanick ML
    Am J Med; 2005 Dec; 118 Suppl 12B():64-73. PubMed ID: 16414329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasomotor symptoms in menopause: physiologic condition and central nervous system approaches to treatment.
    Rapkin AJ
    Am J Obstet Gynecol; 2007 Feb; 196(2):97-106. PubMed ID: 17306645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasomotor menopausal symptoms and risk of coronary heart disease: a life course perspective.
    Hardy R
    Menopause; 2011 Feb; 18(2):127-8. PubMed ID: 21135711
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of menopausal symptoms post-Women's Health Initiative: refinement of existing treatments and development of new therapies.
    Honebrink A
    Expert Opin Emerg Drugs; 2005 Aug; 10(3):619-41. PubMed ID: 16083332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MF101: a multi-component botanical selective estrogen receptor beta modulator for the treatment of menopausal vasomotor symptoms.
    Leitman DC; Christians U
    Expert Opin Investig Drugs; 2012 Jul; 21(7):1031-42. PubMed ID: 22616988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.